Recombinant CALCA, CALCB (Fremanezumab Biosimilar) anticorps
Aperçu rapide pour Recombinant CALCA, CALCB (Fremanezumab Biosimilar) anticorps (ABIN7597700)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Classe de qualité
-
-
Expression System
- Mammalian cells
-
Fonction
- Research Grade Fremanezumab Biosimilar Antibody
-
Specificité
- CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Pureté
- >95 % by SDS-PAGE.
-
Isotype
- IgG2 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Date de péremption
- 12 months
-
-
- CALCA, CALCB (Fremanezumab Biosimilar)
-
Autre désignation
- Fremanezumab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
- CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP
-
UniProt
- P01258, P10092
-
Numéro CAS
- 1655501-53-3
Antigène
-